Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M603107200 on August 21, 2006

J. Biol. Chem., Vol. 281, Issue 42, 31616-31626, October 20, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/42/31616    most recent
M603107200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reinke, A.
Right arrow Articles by Powers, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reinke, A.
Right arrow Articles by Powers, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Caffeine Targets TOR Complex I and Provides Evidence for a Regulatory Link between the FRB and Kinase Domains of Tor1p*

Aaron Reinke, Jenny C.-Y. Chen, Sofia Aronova, and Ted Powers1

From the Section of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis, California 95616

The target of rapamycin (TOR) kinase is an important regulator of growth in eukaryotic cells. In budding yeast, Tor1p and Tor2p function as part of two distinct protein complexes, TORC1 and TORC2, where TORC1 is specifically inhibited by the antibiotic rapamycin. Significant insight into TORC1 function has been obtained using rapamycin as a specific small molecule inhibitor of TOR activity. Here we show that caffeine acts as a distinct and novel small molecule inhibitor of TORC1: (i) deleting components specific to TORC1 but not TORC2 renders cells hypersensitive to caffeine; (ii) rapamycin and caffeine display remarkably similar effects on global gene expression; and (iii) mutations were isolated in Tor1p, a component specific to TORC1, that confers significant caffeine resistance both in vivo and in vitro. Strongest resistance requires two simultaneous mutations in TOR1, the first at either one of two highly conserved positions within the FRB (rapamycin binding) domain and a second at a highly conserved position within the ATP binding pocket of the kinase domain. Biochemical and genetic analyses of these mutant forms of Tor1p support a model wherein functional interactions between the FRB and kinase domains, as well as between the FRB domain and the TORC1 component Kog1p, regulate TOR activity as well as contribute to the mechanism of caffeine resistance.


Received for publication, March 31, 2006 , and in revised form, August 4, 2006.

* This work was supported by National Sciences Foundation Grant MCB-1031221 and by American Cancer Society Research Scholar Grant RSG-04-075-01-TBE (to T. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed. Tel.: 530-754-5052; Fax: 530-752-3085; E-mail: tpowers{at}ucdavis.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
X. L. Guan, C. M. Souza, H. Pichler, G. Dewhurst, O. Schaad, K. Kajiwara, H. Wakabayashi, T. Ivanova, G. A. Castillon, M. Piccolis, et al.
Functional Interactions between Sphingolipids and Sterols in Biological Membranes Regulating Cell Physiology
Mol. Biol. Cell, April 1, 2009; 20(7): 2083 - 2095.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Ohne, T. Takahara, R. Hatakeyama, T. Matsuzaki, M. Noda, N. Mizushima, and T. Maeda
Isolation of Hyperactive Mutants of Mammalian Target of Rapamycin
J. Biol. Chem., November 14, 2008; 283(46): 31861 - 31870.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
T. W. Sturgill, A. Cohen, M. Diefenbacher, M. Trautwein, D. E. Martin, and M. N. Hall
TOR1 and TOR2 Have Distinct Locations in Live Cells
Eukaryot. Cell, October 1, 2008; 7(10): 1819 - 1830.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. J. Tate and T. G. Cooper
Stress-responsive Gln3 Localization in Saccharomyces cerevisiae Is Separable from and Can Overwhelm Nitrogen Source Regulation
J. Biol. Chem., June 22, 2007; 282(25): 18467 - 18480.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
E. M. Rubenstein and M. C. Schmidt
Mechanisms Regulating the Protein Kinases of Saccharomyces cerevisiae
Eukaryot. Cell, April 1, 2007; 6(4): 571 - 583.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Urano, T. Sato, T. Matsuo, Y. Otsubo, M. Yamamoto, and F. Tamanoi
Point mutations in TOR confer Rheb-independent growth in fission yeast and nutrient-independent mammalian TOR signaling in mammalian cells
PNAS, February 27, 2007; 104(9): 3514 - 3519.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement